Depletion of naive T cells from stem cell grafts limits chronic graft-versus host disease

Stem cell transplantation is used to treat hematologic malignancies, such as leukemia. Patients who receive donor cells are at risk of developing graft-versus host disease (GVHD).

[Read the full article here]

Comments are closed.